Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

Table 2 Baseline characteristics in AMI patients according to MAGE

MAGE (mmol/L)	<2.37	2.37-3.65	>3.65	P-value
Subject number	80	78	79	NA
Age (years)	51 ± 13	53 ± 15	57 ± 16	0.034
Males	55 (69)	53 (68)	57 (72)	0.831
BMI, kg/m²	24.7 ± 3.9	25.1 ± 4.2	25.4 ± 4.5	0.575
LVEF, %	55.8 ± 7.5	52.5 ± 8.1	51.2 ± 8.4	0.001
Systolic BP (mm Hg)	119 ± 21	121 ± 27	123 ± 25	0.533
Diastolic BP (mm Hg)	70 ± 11	69 ± 12	71 ± 15	0.619
Serum creatinine, mg/dL	0.79 ± 0.25	0.80 ± 0.23	0.82 ± 0.27	0.745
Total Cholesterol (mmol/l)	4.61 ± 1.15	4.63 ± 1.18	4.67 ± 1.09	0.387
Triglycerides (mmol/l)	2.20 ± 1.18	2.18 ± 1.35	2.31 ± 1.43	0.802
HbA1c (%)	6.1 ± 1.4	6.4. ± 1.3	7.0 ± 1.5	<0.001
Glycated albumin (%)	11.8 ± 6.5	16.8 ± 7.7	19.9 ± 8.5	<0.001
Peak CK-MB (ng/ml)	35.1 ± 11.6	37.2 ± 13.4	39.5 ± 14.5	0.113
Peak cTNI (ng/ml)	35.3 ± 12.7	36.9 ± 12.5	40.2 ± 11.4	0.038
MBG (mmol/l)	6.9 ± 1.2	8.1 ± 2.1	9.5 ± 1.9	<0.001
Risk factors (n, %)
Hyperlipidemia	28 (35)	31 (40)	34 (43)	0.580
Hypertension	27 (34)	35 (45)	33 (42)	0.337
Current smoking	31 (39)	33 (42)	42 (53)	0.164
Family history	8 (10)	9 (12)	12 (15)	0.592
Obesity	14 (18)	18 (23)	23 (29)	0.222
Diabetes	11 (14)	20 (26)	42 (53)	<0.001
Previous medication [n (%)]
Aspirin	67 (84)	66 (85)	69 (87)	0.801
ACEI or ARB	45 (56)	48 (62)	50 (63)	0.639
β-Blockers	38 (48)	36 (46)	40 (51)	0.847
Statin	37 (46)	39 (50)	41 (52)	0.769
Angiographic data [n (%)]
Single vessel	38 (48)	32 (41)	22 (28)	0.035
Double vessels	27 (34)	26 (33)	24 (30)	0.885
Triple vessels	15 (19)	20 (26)	33 (42)	0.005
Main stem involved	8 (10)	11 (14)	13 (16)	0.483
Multivessel	42 (66)	46 (72)	57 (81)	0.037
TIMI-3 flow after PCI	74 (93)	73 (94)	71 (90)	0.678

Data given as mean ± SD or n (%).
BMI, body mass index; LVEF, left ventricular ejection fraction; LDL-C, Low density lipoprotein-cholesterol; HDL-C, High density lipoprotein-cholesterol; HbA1c, hemoglobin A1c; CK-MB, creatine kinase-MB; cTnI, cardiac troponin I; FBG, fasting blood glucose; OHA, oral hypoglycaemic agent; MBG, Mean blood glucose; MAGE, the mean amplitude of glycemic excursions; SDBG, the standard deviation of blood glucose values.

ISSN: 1758-5996